NewLimit Revenue and Competitors
Estimated Revenue & Valuation
- NewLimit's estimated annual revenue is currently $2.6M per year.
- NewLimit's estimated revenue per employee is $65,577
- NewLimit's total funding is $72M.
Employee Data
- NewLimit has 39 Employees.
- NewLimit grew their employee count by 22% last year.
NewLimit's People
| Name | Title | Email/Phone |
|---|
NewLimit Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 5 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 4 | -50% | N/A | N/A |
#6 | $0.7M | 8 | 0% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 17 | 31% | N/A | N/A |
What Is NewLimit?
NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.
keywords:N/A
$72M
Total Funding
39
Number of Employees
$2.6M
Revenue (est)
22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.1M | 39 | -17% | $100.3M |
#2 | $3.5M | 39 | 3% | N/A |
#3 | $7.5M | 39 | 5% | N/A |
#4 | $6.6M | 39 | -28% | N/A |
#5 | $4.4M | 39 | N/A | N/A |